Galecto Stock Analysis

Galecto Stock Analysis Notes

About 13.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 12.11. Galecto had not issued any dividends in recent years. The entity had 1:25 split on the 30th of August 2024. Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. Galecto operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. To learn more about Galecto call the company at 45 70 70 52 10 or check out https://galecto.com.

Galecto Investment Alerts

Galecto Upcoming and Recent Events

Galecto Largest EPS Surprises

View All Earnings Estimates

Galecto Environmental, Social, and Governance (ESG) Scores

Galecto Stock Institutional Investors

Note, although Galecto's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Galecto Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 43.73 M.

Galecto Profitablity

Management Efficiency

Galecto has return on total asset (ROA) of (0.4354) % which means that it has lost $0.4354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0949) %, meaning that it created substantial loss on money invested by shareholders. Galecto's management efficiency ratios could be used to measure how well Galecto manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of December 2025, Return On Tangible Assets is likely to drop to -1.31. In addition to that, Return On Capital Employed is likely to drop to -1.47. At this time, Galecto's Other Current Assets are very stable compared to the past year. As of the 30th of December 2025, Debt To Assets is likely to grow to 0.01, while Total Assets are likely to drop about 16.3 M.

Technical Drivers

As of the 30th of December, Galecto retains the Risk Adjusted Performance of 0.1219, downside deviation of 10.49, and Market Risk Adjusted Performance of 1.79. Galecto technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Galecto Price Movement Analysis

Galecto Insider Trading Activities

Galecto Outstanding Bonds

Galecto Predictive Daily Indicators

Galecto Corporate Filings

Galecto Forecast Models

Galecto's time-series forecasting models are one of many Galecto's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Galecto's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Galecto prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Galecto shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Galecto. By using and applying Galecto Stock analysis, traders can create a robust methodology for identifying Galecto entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Galecto analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Galecto analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Galecto stock analysis indicators help investors evaluate how Galecto stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Galecto shares will generate the highest return on investment. By understating and applying Galecto stock analysis, traders can identify Galecto position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galecto. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Galecto Stock, please use our How to Invest in Galecto guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galecto. If investors know Galecto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galecto listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galecto's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.